Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Advanced Soft Tissue Sarcomas

This randomized trial compares the effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on overall survival in patients with advanced/metastatic soft tissue sarcoma and leiomyosarcoma.
Source: JAMA - Category: General Medicine Source Type: research